Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platform
What You Should Know Structural biology and AI drug design pioneer Chai Discovery has announced a $400M Series C funding round, valuing the company at $3.8 billion just two years after its 2024 founding. The heavily oversubscribed round was led by Index Ventures, alongside Kleiner Perkins, Sequoia Capital, and Dimension, with strategic backing from existing…